Ahmad Mourad in Tulsa, Oklahoma

Medical School: Sorry, his university is not listed
Graduation Year: 2000
The Primary Medical Specialty for Ahmad Mourad is listed as: Allergy/immunology
Approximate Years of Experience: 25
PAC (PECOS ID)#: 6709061591
NPI #: 1861425720
NPI Created On: 07/07/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 208000000X
License Number:
4301081664
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Arabic, ARABIC, ENGLISH.

Services and Procedures include:

1. Vaccine for influenza for injection into muscle
2. Measurement and graphic recording of total and timed exhaled air capacity
3. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
4. Injection of allergenic extracts into skin, accessed through the skin
5. Measurement of inhaled nitric oxide gas
6. Injection of allergenic extracts into skin for immediate reaction analysis
7. Injection of incremental dosages of allergen
8. Injection of incremental dosages of allergen, 2 or more injections
9. Preparation and provision of single or multiple antigens for allergen immunotherapy
10. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
11. Infusion into a vein for therapy, prevention, or diagnosis
12. Infusion into tissue for therapy or prevention up to 1 hour
13. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
14. New patient office or other outpatient visit, typically 30 minutes
15. New patient office or other outpatient visit, typically 45 minutes
16. Established patient office or other outpatient visit, typically 15 minutes
17. Established patient office or other outpatient, visit typically 25 minutes
18. Administration of influenza virus vaccine
19. Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
20. Injection, omalizumab, 5 mg